“The RNA team helped us from inception through our IPO and beyond. They are one of the top firms that I know of at the intersection of valuation, biotech and finance. I’d recommend them for my life science venture-backed company colleagues.”
“I inherited the RNA team from the previous CFO and we’ve found them to be fantastic. They get healthcare, valuation, and they get the psychology of value just as much as the tools. They know how to get things done.”
“RNA knows the diagnostics space. From Nanosphere to Biocartis, RNA has been my valuation firm of choice. They are responsive, efficient and I know that they’ll deliver. I’ve been glad to see their success and growth. It’s well deserved.”
“We started working with the RNA team when we realized that the large branded firm that we were working with needed too much hand holding to understand our investments and the royalty industry. We switched to RNA because they understand the sector, are responsive and efficient, and are in the flow of the biopharma ecosystem.”
Enter your email address below to receive updates from RNA Advisors.